Patent ID: 7846966

Claim:
A method of treating an estrogen-receptor related condition in a patient, comprising: administering to the patient an effective amount of a compound having the Formula 1 in which R 1 is (1C-4C)alkyl, (2C-4C)alkenyl or (2C-4C)alkynyl, and independently R 1 has a cis-orientation in relation to the exocyclic phenyl group at the 2-position of the skeleton; R 4 is H, Hal, CF 3 , OH or (1C-2C)alkyloxy; and R 2 , R 3 , and R 5 are independently H, Hal, CF 3 , (1C-4C)alkyl, (2C-4C)alkenyl or (2C-4C)alkynyl; or a prodrug thereof, wherein the estrogen-related condition is benign prostate hypertrophy, or peri- and/or post-menopausal complaints.